Supplementary Figure 4: Frequency of the p.Arg138* variant in Europe.
From: Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
The p.Arg138* variant was genotyped in individuals from Finland, Sweden, Denmark, the UK, and Poland (through the Illumina Human Exome Array or custom Sequenom genotyping), as well as Iceland (through whole genome sequencing). Shown are the observed frequencies of the variant in each country; frequency estimates from Finland are stratified by the Botnia region (individuals from the Botnia cohort) and other regions of Finland. N indicates the number of individuals genotyped.
